Polymorphisms in PPAR genes (PPARD, PPARG, and PPARGC1A) and the risk of chronic kidney disease in Japanese: Cross-sectional data from the J-MICC study

PPAR Research

Volumn , Issue , 2013, Pages

  Hishida, Asahi ^a   Wakai, Kenji ^a   Naito, Mariko ^a   Tamura, Takashi ^a   Kawai, Sayo ^a   Hamajima, Nobuyuki ^a   Oze, Isao ^b   Imaizumi, Takeshi ^c   Turin, Tanvir Chowdhury ^d,e   Suzuki, Sadao ^f   Kheradmand, Motahare ^g   Mikami, Haruo ^h   Ohnaka, Keizo ⁱ   Watanabe, Yoshiyuki ^j   Arisawa, Kokichi ^k   Kubo, Michiaki ^l   Tanaka, Hideo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF CALGARY   (Canada)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

^h CHIBA CANCER CENTER   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^k UNIVERSITY OF TOKUSHIMA   (Japan)

^l RIKEN   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOGENESIS;

EID: 84888874108     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/980471     Document Type: Article

References (42)

1. Yamamoto R., Kanazawa A., Shimizu T., Hirose T., Tanaka Y., Kawamori R., Watada H., Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice 2009 84 1 39 45 2-s2.0-62049083007 10.1016/j.diabres.2009.01.009
2. Nagata M., Ninomiya T., Doi Y., Yonemoto K., Kubo M., Hata J., Tsuruya K., Iida M., Kiyohara Y., Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama study. Nephrology Dialysis Transplantation 2010 25 8 2557 2564 2-s2.0-77954768806 10.1093/ndt/gfq062
3. Iseki K., Chronic kidney disease in Japan from early predictions to current facts. Nephron 2008 110 4 c268 c272 2-s2.0-55449094956 10.1159/000170094
4. Ninomiya T., Kiyohara Y., Chronic kidney diseases and other diseases: 1. Cardiovascular diseases Nihon Naika Gakkai Zasshi 2007 96 5 887 893 2-s2.0-34447126311
5. Matsuo S., Yasuda Y., Imai E., Horio M., Current status of estimated glomerular filtration rate (eGFR) equations for Asians and an approach to create a common eGFR equation. Nephrology 2010 15 supplement 2 45 48 2-s2.0-77952595678 10.1111/j.1440-1797.2010.01313.x
6. Perlstein T. S., Gerhard-Herman M., Hollenberg N. K., Williams G. H., Thomas A., Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. Journal of the American Society of Nephrology 2007 18 3 944 951 2-s2.0-33947289912 10.1681/ASN.2006091026 (Pubitemid 46434511)
7. Gluba A., Mikhailidis D. P., Lip G. Y. H., Hannam S., Rysz J., Banach M., Metabolic syndrome and renal disease. International Journal of Cardiology 2013 164 2 141 150 2-s2.0-84856405531 10.1016/j.ijcard.2012.01.013
8. Echouffo-Tcheugui J. B., Kengne A. P., Risk models to predict chronic kidney disease and its progression: a systematic review. PLOS Medicine 2012 9 11 e1001344 10.1371/journal.pmed.1001344
9. Evans R. M., Barish G. D., Wang Y. X., PPARs and the complex journey to obesity. Nature Medicine 2004 10 4 355 361 2-s2.0-1942518840 10.1038/nm1025 (Pubitemid 38508511)
10. Nikitin A. G., Chistiakov D. A., Minushkina L. O., Zateyshchikov D. A., Nosikov V. V., Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart and Vessels 2010 25 3 229 236 2-s2.0-77956154620 10.1007/s00380-009-1159-9
11. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 2006 45 2 120 159 2-s2.0-32644460092 10.1016/j.plipres.2005.12.002 (Pubitemid 43248732)
12. Azhar S., Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiology 2010 6 5 657 691 2-s2.0-77958060003 10.2217/fca.10.86
13. Grimaldi P. A., Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor β Current Opinion in Lipidology 2010 21 3 186 191 2-s2.0-77952392529 10.1097/MOL.0b013e32833884a4
14. Ruan X., Zheng F., Guan Y., PPARs and the kidney in metabolic syndrome. American Journal of Physiology 2008 294 5 F1032 F1047 2-s2.0-45149134035 10.1152/ajprenal.00152.2007
15. Bhatt S. P., Nigam P., Misra A., Guleria R., Luthra K., Pandey R. M., Pasha M. A., Association of peroxisome proliferator activated receptor- γ gene with non-alcoholic fatty liver disease in Asian Indians residing in North India. Gene 2013 512 1 143 147 10.1016/j.gene.2012.09.067
16. Uemura H., Hiyoshi M., Arisawa K., Yamaguchi M., Naito M., Kawai S., Hamajima N., Matsuo K., Taguchi N., Takashima N., Suzuki S., Hirasada K., Mikami H., Ohnaka K., Yoshikawa A., Kubo M., Tanaka H., Gene variants in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population. Maturitas 2012 71 4 369 375 2-s2.0-84858082664 10.1016/j.maturitas. 2011.12.021
17. Hamajima N., J-MICC Study Group, The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer. Asian Pacific Journal of Cancer Prevention 2007 8 2 317 323 2-s2.0-40449117476
18. Wakai K., Hamajima N., Okada R., Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study to elucidate associations between genotypes and lifestyle and clinical factors: a project in the Japan Multi-institutional Collaborative Cohort (J-MICC) Study. Journal of Epidemiology 2010 21 3 223 235 10.2188/jea.JE20100139
19. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., Revised equations for estimated GFR from serum creatinine in Japan. American Journal of Kidney Diseases 2009 53 6 982 992 2-s2.0-65549111017 10.1053/j.ajkd.2008.12.034
20. Ohnishi Y., Tanaka T., Ozaki K., Yamada R., Suzuki H., Nakamura Y., A high-throughput SNP typing system for genome-wide association studies. Journal of Human Genetics 2001 46 8 471 477 2-s2.0-0034885541 10.1007/s100380170047 (Pubitemid 32744120)
21. Budtz-Jørgensen E., Keiding N., Grandjean P., Weihe P., Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure. Annals of Epidemiology 2007 17 1 27 35 2-s2.0-33845513945 10.1016/j.annepidem.2006.05.007 (Pubitemid 44920370)
22. Weinberg C. R., Toward a clearer definition of confounding. American Journal of Epidemiology 1993 137 1 1 8 2-s2.0-0027468093 (Pubitemid 23077302)
23. Ito T., Inoue E., Kamatani N., Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances. Genetics 2004 168 4 2339 2348 2-s2.0-5144228417 10.1534/genetics.103.024653 (Pubitemid 40066366)
24. Andrulionyte L., Peltola P., Chiasson J. L., Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 2006 55 7 2148 2152 2-s2.0-33747060509 10.2337/db05-1629 (Pubitemid 44509991)
25. Stefan N., Thamer C., Staiger H., Machicao F., Machann J., Schick F., Venter C., Niess A., Laakso M., Fritsche A., Häring H.-U., Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. Journal of Clinical Endocrinology and Metabolism 2007 92 5 1827 1833 2-s2.0-34249852535 10.1210/jc.2006-1785 (Pubitemid 46997196)
26. Tovar-Palacio C., Torres N., Diaz-Villaseñor A., Tovar A. R., The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes & Nutrition 2012 7 4 483 498 10.1007/s12263-012-0295-5
27. Yoshida T., Kato K., Yokoi K., Watanabe S., Metoki N., Satoh K., Aoyagi Y., Nishigaki Y., Nozawa Y., Yamada Y., Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension. Hypertension Research 2009 32 5 411 418 2-s2.0-68249159779 10.1038/hr.2009.22
28. Grarup N., Albrechtsen A., Ek J., Borch-Johnsen K., Jørgensen T., Schmitz O., Hansen T., Pedersen O., Variation in the peroxisome proliferator-activated receptor δ gene in relation to common metabolic traits in 7,495 middle-aged white people. Diabetologia 2007 50 6 1201 1208 2-s2.0-34247844401 10.1007/s00125-007-0668-2 (Pubitemid 46701567)
29. Shin H. D., Park B. L., Kim L. H., Jung H. S., Cho Y. M., Moon M. K., Park Y. J., Lee H. K., Park K. S., Genetic polymorphisms in peroxisome proliferator-activated receptor δ associated with obesity. Diabetes 2004 53 3 847 851 2-s2.0-1442301053 10.2337/diabetes.53.3.847 (Pubitemid 38270658)
30. Lu L., Wu Y., Qi Q., Liu C., Gan W., Zhu J., Li H., Lin X., Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly chinese. PLoS ONE 2012 7 4 2-s2.0-84859598450 10.1371/journal.pone.0034895 e34895
31. Hu C., Jia W., Fang Q., Zhang R., Wang C., Lu J., Xiang K., Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabetic Medicine 2006 23 12 1307 1312 2-s2.0-33751251346 10.1111/j.1464-5491.2006.02001.x (Pubitemid 44787793)
32. HapMap homepage, http://www.hapmap.org
33. Nikitin A. G., Chistiakov D. A., Minushkina L. O., Zateyshchikov D. A., Nosikov V. V., Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart and Vessels 2010 25 3 229 236 2-s2.0-77956154620 10.1007/s00380-009-1159-9
34. Chehaibi K., Hrira M. Y., Rouis M., Najah M., Jguirim-Souissi I., Nouira S., Slimane M. N., Effect of genetic polymorphism +294T/C in peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in a Tunisian population. Journal of Molecular Neuroscience 2013 50 2 360 367 10.1007/s12031-013-9997-4
35. Skogsberg J., Kannisto K., Cassel T. N., Hamsten A., Eriksson P., Ehrenborg E., Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 637 643 2-s2.0-0037387593 10.1161/01.ATV.0000064383. 88696.24 (Pubitemid 36438077)
36. He T. C., Chan T. A., Vogelstein B., Kinzler K. W., PPAR δ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999 99 3 335 345 2-s2.0-0033615352 10.1016/S0092-8674(00)81664-5 (Pubitemid 29519912)
37. Lee C. H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Transcriptional repression of atherogenic inflammation: modulation by PPAR δ Science 2003 302 5644 453 457 2-s2.0-0142116239 10.1126/science.1087344 (Pubitemid 37296272)
38. Zhang H., Zhu S., Chen J., Tang Y., Hu H., Mohan V., Venkatesan R., Wang J., Chen H., Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. Diabetes Care 2012 35 6 1388 1393 10.2337/dc11-2142
39. Gayathri S. B., Radha V., Vimaleswaran K. S., Mohan V., Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian indian population (CURES-41). Metabolic Syndrome and Related Disorders 2010 8 2 119 126 2-s2.0-77950617876 10.1089/met.2009.0040
40. Yang Y., Mo X., Chen S., Lu X., Gu D., Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis. Diabetes/Metabolism Research and Reviews 2011 27 2 177 184 2-s2.0-79551603558 10.1002/dmrr.1158
41. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2012 2 1 138 10.1038/kisup.2012.1
42. Nakagawa S., A farewell to Bonferroni: the problems of low statistical power and publication bias. Behavioral Ecology 2004 15 6 1044 1045 2-s2.0-8144231087 10.1093/beheco/arh107 (Pubitemid 39471217)